Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets

IQVIA HOLDINGS INC. Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets

IQVIA HOLDINGS INC. (IQV) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets of 4.05% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-11.

Discontinued › Expense Statement › Operating Expenses

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets · last filed 2016-02-11

  • IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2015 was 4.05%, a 22.26% decline from fiscal 2014.
  • IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2014 was 5.21%, a 2.25% decline from fiscal 2013.
  • IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2013 was 5.33%, a 1.91% increase from fiscal 2012.
  • IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2012 was 5.23%, a 15.24% decline from fiscal 2011.
Period endDefined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets 12 month
2015-12-314.05%
10-K · filed 2016-02-11
2014-12-315.21%
10-K · filed 2016-02-11
2013-12-315.33%
10-K · filed 2016-02-11
2012-12-315.23%
10-K · filed 2015-02-12
2011-12-316.17%
10-K · filed 2014-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B